89bio Inc (ETNB)
8.38
+0.40
(+5.01%)
USD |
NASDAQ |
Nov 21, 16:00
8.38
0.00 (0.00%)
After-Hours: 19:54
89bio Enterprise Value: 550.08M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 550.08M |
| November 19, 2024 | 551.25M |
| November 18, 2024 | 549.49M |
| November 15, 2024 | 544.20M |
| November 14, 2024 | 640.61M |
| November 13, 2024 | 557.89M |
| November 12, 2024 | 572.21M |
| November 11, 2024 | 678.34M |
| November 08, 2024 | 720.79M |
| November 07, 2024 | 668.79M |
| November 06, 2024 | 691.07M |
| November 05, 2024 | 591.32M |
| November 04, 2024 | 597.68M |
| November 01, 2024 | 581.76M |
| October 31, 2024 | 437.43M |
| October 30, 2024 | 459.72M |
| October 29, 2024 | 479.88M |
| October 28, 2024 | 462.90M |
| October 25, 2024 | 446.98M |
| October 24, 2024 | 436.37M |
| October 23, 2024 | 440.62M |
| October 22, 2024 | 473.52M |
| October 21, 2024 | 474.58M |
| October 18, 2024 | 497.92M |
| October 17, 2024 | 483.07M |
| Date | Value |
|---|---|
| October 16, 2024 | 525.52M |
| October 15, 2024 | 462.90M |
| October 14, 2024 | 451.23M |
| October 11, 2024 | 438.49M |
| October 10, 2024 | 401.35M |
| October 09, 2024 | 387.55M |
| October 08, 2024 | 398.17M |
| October 07, 2024 | 389.68M |
| October 04, 2024 | 374.82M |
| October 03, 2024 | 371.63M |
| October 02, 2024 | 382.25M |
| October 01, 2024 | 392.86M |
| September 30, 2024 | 397.10M |
| September 27, 2024 | 262.12M |
| September 26, 2024 | 273.24M |
| September 25, 2024 | 279.59M |
| September 24, 2024 | 295.48M |
| September 23, 2024 | 306.07M |
| September 20, 2024 | 361.14M |
| September 19, 2024 | 371.73M |
| September 18, 2024 | 373.85M |
| September 17, 2024 | 378.09M |
| September 16, 2024 | 363.26M |
| September 13, 2024 | 391.86M |
| September 12, 2024 | 350.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-64.08M
Minimum
May 09 2022
1.149B
Maximum
Jun 13 2023
326.19M
Average
282.21M
Median
Jun 10 2020
Enterprise Value Benchmarks
| Madrigal Pharmaceuticals Inc | 6.034B |
| Eli Lilly and Co | 742.91B |
| Viking Therapeutics Inc | 4.812B |
| Akero Therapeutics Inc | 1.456B |
| NovaBay Pharmaceuticals Inc | 2.745M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -149.07M |
| Total Expenses (Quarterly) | 151.94M |
| EPS Diluted (Quarterly) | -1.39 |
| Earnings Yield | -34.73% |